article thumbnail

metaMe Health Raises $2.2M in Funding

HPA

We’re excited to share that metaMe Health , a prescription digital therapeutics (PDT) company, today announced raising $2.2M Ken Greisman , the HPA Deal Lead and a veteran of the pharmaceutical industry, has joined the metaMe board of directors. in funding. and chief legal officer at Takeda Pharmaceuticals U.S.A.,

health 113
article thumbnail

metaMe Health Raises $2.2M in Funding

HPA

We’re excited to share that metaMe Health , a prescription digital therapeutics (PDT) company, today announced raising $2.2M Ken Greisman , the HPA Deal Lead and a veteran of the pharmaceutical industry, has joined the metaMe board of directors. in funding. and chief legal officer at Takeda Pharmaceuticals U.S.A.,

health 91
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

[DarioHealth in PR Newswire] Diabetes and Behavioral Health Global Experts Join DarioHealth Scientific Advisory Board Expanding Innovation Leadership in Digital Therapeutics for Chronic Care D

OurCrowd

The post [DarioHealth in PR Newswire] Diabetes and Behavioral Health Global Experts Join DarioHealth Scientific Advisory Board Expanding Innovation Leadership in Digital Therapeutics for Chronic Care D appeared first on OurCrowd Blog. Read more here.

article thumbnail

[Sweetch in PR Newswire] Sweetch Strengthens its Advisory Board with Appointment of Diabetes Care Leader, Dr. Robert A. Gabbay

OurCrowd

TEL AVIV, Israel, April 26, 2022 /PRNewswire/ — Sweetch, a digital therapeutics innovator and creator of the precision engagement platform for chronic conditions, announced today that Robert A. The post [Sweetch in PR Newswire] Sweetch Strengthens its Advisory Board with Appointment of Diabetes Care Leader, Dr. Robert A.

article thumbnail

Biofourmis hits unicorn status after $300m Series D funding

AsiaTechDaily

Register Biofourmis , a Sigapore-founded digital therapeutics firm , announced that it has surpassed unicorn status with a $300 million Series D investment led by leading global growth equity firm General Atlantic. Bookmark ( 0 ) Please login to bookmark Username or Email Address Password Remember Me No account yet?

article thumbnail

[Sweetch in PR Newswire] Sweetch strengthens Advisory Board with appointment of obesity medicine expert and innovator, Dr. Fatima Cody Stanford

OurCrowd

16, 2022 Sweetch, a digital therapeutics innovator and creator of the precision engagement platform for chronic conditions, announced today that Fatima Cody Stanford MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS has joined the company as an advisor. TEL AVIV, Israel, Nov. Read more on PR Newswire here.

article thumbnail

[DarioHealth in Yahoo Finance] DarioHealth Appoints Eric Milledge as Chairman of its Newly Established Scientific Advisory Board

OurCrowd

(Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announces that Eric Milledge has joined DarioHealth as Chairman of the company’s newly-established Scientific Advisory Board (SAB). Read more here.